The prevalence of chronic postmastectomy pain syndrome in female breast cancer survivors

dc.contributor.authorVariawa, Muhammed Luqmaanen_ZA
dc.contributor.authorScribante, Juanen_ZA
dc.contributor.authorPerrie, Helenen_ZA
dc.contributor.authorChetty, Seanen_ZA
dc.date.accessioned2020-02-26T07:45:33Z
dc.date.available2020-02-26T07:45:33Z
dc.date.issued2016
dc.descriptionCITATION: Variawa, M. L., et al. 2016. The prevalence of chronic postmastectomy pain syndrome in female breast cancer survivors. Southern African Journal of Anaesthesia and Analgesia, 22(4):108-113, doi:10.1080/22201181.2016.1191214.
dc.descriptionThe original publication is available at https://www.tandfonline.com
dc.description.abstractBackground: Breast cancer is one of the most common cancer diagnoses in women. Surgical treatment is indicated in most patients. Postmastectomy pain syndrome (PMPS) is a debilitating neuropathic pain syndrome that develops after breast surgery. A review of the literature revealed no studies determining the prevalence of PMPS conducted in South Africa. The current anecdotal perception is that the prevalence of PMPS in the African population is low. Objectives: The objectives of this study were to determine the prevalence of PMPS in adult female breast cancer patients following general anaesthesia without regional anaesthesia at the Chris Hani Baragwanath Academic Hospital (CHBAH), as well as the impact of various clinical and demographic variables on the prevalence of PMPS. Methods: The research design was a cross-sectional descriptive study. The validated DN4 pain questionnaire was used in this study. Results: The study included 92 patients. The prevalence of PMPS was found to be 38.04% (n = 35). The average duration that patients experienced neuropathic pain symptoms was 12.22 months (range 3–39 months). The average age of patients interviewed was 58.54 years (range 30–90 years). There was no statistically significant difference between age group and PMPS (p = 0.47). The study also showed that no statistically significant association existed between pain experienced and adjuvant therapy administered. Conclusion: Even though surgical procedures are becoming less invasive, the prevalence of PMPS after treatment for breast cancer remains a clinically significant problem, comparable to international literature. This necessitates the development of more effective prevention and treatment strategies to improve patients’ quality of life.en_ZA
dc.description.urihttps://www.tandfonline.com/doi/full/10.1080/22201181.2016.1191214#.VQcjlpWJhgU
dc.description.versionPublisher's version
dc.format.extent7 pages
dc.identifier.citationVariawa, M. L., et al. 2016. The prevalence of chronic postmastectomy pain syndrome in female breast cancer survivors. Southern African Journal of Anaesthesia and Analgesia, 22(4):108-113, doi:10.1080/22201181.2016.1191214
dc.identifier.issn2220-1173 (online)
dc.identifier.issn2220-1181 (print)
dc.identifier.otherdoi:10.1080/22201181.2016.1191214
dc.identifier.urihttp://hdl.handle.net/10019.1/107541
dc.language.isoen_ZAen_ZA
dc.publisherTaylor & Francis Group
dc.rights.holderAuthors retain copyright
dc.subjectBreast -- Cancer -- Patientsen_ZA
dc.subjectMastectomy -- Patientsen_ZA
dc.subjectCronic postmastectomy pain syndromeen_ZA
dc.subjectNeuropathic painen_ZA
dc.titleThe prevalence of chronic postmastectomy pain syndrome in female breast cancer survivorsen_ZA
dc.typeArticleen_ZA
Files
Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
variawa_prevalence_2016.pdf
Size:
481.27 KB
Format:
Adobe Portable Document Format
Description:
Download article
License bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: